ArticleCell death & disease2023

Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer.

Soon Young Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.